RECRUITING

RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care

Official Title

Telemedicine-delivered Digital Cognitive Behavioral Intervention to Decrease Post-operative Opioid Use Among Patients Undergoing Total Knee or Hip Arthroplasty

Quick Facts

Study Start:2023-01-27
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05658796

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Ata Murat Kaynar, MD, MPH
CONTACT
412-383-3463
kaynarm@upmc.edu
Carly Riedmann, MPH
CONTACT
412-623-4147
riedmannca@upmc.edu

Principal Investigator

Ata Murat Kaynar, MD, MPH
PRINCIPAL_INVESTIGATOR
UPMC Department of Anesthesiology and Perioperative Medicine

Study Locations (Sites)

UPMC East
Monroeville, Pennsylvania, 15146
United States
UPMC Shadyside
Pittsburgh, Pennsylvania, 15232
United States
UPMC Passavant
Pittsburgh, Pennsylvania, 15237
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • Ata Murat Kaynar, MD, MPH, PRINCIPAL_INVESTIGATOR, UPMC Department of Anesthesiology and Perioperative Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-27
Study Completion Date2025-07

Study Record Updates

Study Start Date2023-01-27
Study Completion Date2025-07

Terms related to this study

Additional Relevant MeSH Terms

  • Mood Disorders
  • Anxiety
  • Depressive Symptoms
  • Depression
  • Anxiety Disorders
  • Anxiety Depression